Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical excision vs photodynamic therapy vs topical 5-fluorouracil for Bowen's disease
2018-004685-33Phase 4Active
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fluorouracil in Bowen disease (BD) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Sustained clearance rate. Started May 2019; status: active.
02
Drugs
fluorouracil
03
Conditions
Bowen disease (BD)
Beyond the preview
Go deeper on 2018-004685-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004685-33.